Exact Sciences

Company profile

About Exact Sciences

Exact Sciences is a leading molecular diagnostics company dedicated to eradicating cancer through prevention, early detection, and personalized treatment guidance. Founded in 1995 and headquartered in Madison, Wisconsin, the company has grown to serve over 120 countries with more than 6,500 employees globally. Exact Sciences develops and commercializes innovative cancer tests that explore hereditary risks, screen for cancer's presence, and examine the unique genomic alterations of an individual's cancer to help guide treatment decisions. The company's portfolio includes the widely-adopted Cologuard colorectal cancer screening test, the Oncotype DX suite of genomic tests for breast and colon cancer treatment guidance, and newer innovations like the Cancerguard multi-cancer early detection test. With nine research and development centers and state-of-the-art laboratories, Exact Sciences combines rigorous research, deep clinical expertise, and proven accuracy to deliver life-changing diagnostic solutions. The company has tested over 4 million people in 2023 alone and maintains strong collaborations with leading medical institutions, advocacy partners, and policymakers. Exact Sciences went public in February 2001 and has been certified as a Great Place to Work for seven consecutive years, reflecting its commitment to innovation, integrity, quality, teamwork, and accountability in the fight against cancer.

Company description · Exact Sciences official website